Search | Engineering

Subscribe Submit

Home Journals Focus Achievement Fronts About Us 中文版

Resource Type

Journal Article 2

Year

2023 1

2017 1

Keywords

CTC 1

MRD 1

cell-free ctDNA 1

circulating tumor cells 1

ctDNA 1

exosomes 1

liquid biopsy 1

precision medicine 1

solid tumor 1

open ︾

Search scope:

排序： Display mode:

Minimal residual disease in solid tumors: an overview

Frontiers of Medicine 2023, Volume 17, Issue 4, Pages 649-674 doi: 10.1007/s11684-023-1018-6

Abstract: Minimal residual disease (MRD) is termed as the small numbers of remnant tumor cells in a subset of patients with tumors. Liquid biopsy is increasingly used for the detection of MRD, illustrating the potential of MRD detection to provide more accurate management for cancer patients. As new techniques and algorithms have enhanced the performance of MRD detection, the approach is becoming more widely and routinely used to predict the prognosis and monitor the relapse of cancer patients. In fact, MRD detection has been shown to achieve better performance than imaging methods. On this basis, rigorous investigation of MRD detection as an integral method for guiding clinical treatment has made important advances. This review summarizes the development of MRD biomarkers, techniques, and strategies for the detection of cancer, and emphasizes the application of MRD detection in solid tumors, particularly for the guidance of clinical treatment.

Keywords： MRD solid tumor CTC ctDNA